Human CD4+CD25+Foxp3+ regulatory T cells do not constitutively express IL-35

Journal of Immunology

Volumn 181, Issue 10, 2008, Pages 6898-6905

  Bardel, Emilie ^a   Larousserie, Frédérique ^a,b   Charlot Rabiega, Pascaline ^a   Coulomb L'Herminé, Aurore ^c   Devergne, Odile ^a  

^a CNRS   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c ARMAND TROUSSEAU HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; CYTOKINE; INTERLEUKIN 35; PROTEIN P35; UNCLASSIFIED DRUG; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; INTERLEUKIN 35, HUMAN; INTERLEUKIN DERIVATIVE; INTERLEUKIN-35, HUMAN;

ANIMAL CELL; ARTICLE; CD4+ CD25+ FOXP3+ T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; EBV INDUCED GENE 3; EFFECTOR CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN GENOME; IMMUNOBLOTTING; INTESTINE; LYMPH NODE; LYMPHOCYTE ACTIVATION; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PURIFICATION; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN; STAINING; T LYMPHOCYTE SUBPOPULATION; THYMUS; TONSIL; BIOSYNTHESIS; CELL CULTURE; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM; WESTERN BLOTTING;

BLOTTING, WESTERN; CELLS, CULTURED; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 58149188484     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.10.6898     Document Type: Article

References (32)

1. Devergne, O., M. Hummel, H. Koeppen, M. M. Le Beau, E. C. Nathanson, E. Kieff, and M. Birkenbach. 1996. A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes. J. Virol. 70: 1143-1153. (Pubitemid 26029036)
2. Pflanz, S., J. C. Timans, J. Cheung, R. Rosales, H. Kanzler, J. Gilbert, L. Hibbert, T. Churakova, M. Travis, E. Vaisberg, et al. 2002. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells. Immunity 16: 779-790. (Pubitemid 34786477)
3. Devergne, O., M. Birkenbach, and E. Kieff. 1997. Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin. Proc. Natl. Acad. Sci. USA 94: 12041-12046. (Pubitemid 27467839)
4. Collison, L. W., C. J. Workman, T. T. Kuo, K. Boyd, Y. Wang, K. M. Vignali, R. Cross, D. Sehy, R. S. Blumberg, and D. A. Vignali. 2007. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450: 566-569.
5. Pflanz, S., L. Hibbert, J. Mattson, R. Rosales, E. Vaisberg, J. F. Bazan, J. H. Phillips, T. K. McClanahan, R. de Waal Malefyt, and R. A. Kastelein. 2004. WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J. Immunol. 172: 2225-2231. (Pubitemid 38182370)
6. Kastelein, R. A., C. A. Hunter, and D. J. Cua. 2007. Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. Annu. Rev. Immunol. 25: 221-242.
7. Batten, M., and N. Ghilardi. 2007. The biology and therapeutic potential of interleukin 27. J. Mol. Med. 85: 661-672.
8. Niedbala, W., X. Q. Wei, B. Cai, A. J. Hueber, B. P. Leung, I. B. McInnes, and F. Y. Liew. 2007. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur. J. Immunol. 37: 3021-3029. (Pubitemid 350131282)
9. Trinchieri, G. 2003. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3: 133-146. (Pubitemid 37328691)
10. Devergne, O., A. Coulomb-L'Herminé, F. Capel, M. Moussa, and F. Capron. 2001. Expression of Epstein-Barr virus-induced gene 3, an interleukin-12 p40-related molecule, throughout human pregnancy: involvement of syncytiotrophoblasts and extravillous trophoblasts. Am. J. Pathol. 159: 1763-1776. (Pubitemid 33062519)
11. Coulomb-L'Herminé, A., F. Larousserie, S. Pflanz, E. Bardel, R. Kastelein, and O. Devergne. 2007. Expression of interleukin-27 by human trophoblast cells. Placenta 28: 1133-1140. (Pubitemid 47570908)
12. Larousserie, F., S. Pflanz, A. Coulomb-L'Herminé, N. Brousse, R. Kastelein, and O. Devergne. 2004. Expression of IL-27 in human Th1-associated granulomatous diseases. J. Pathol. 202: 164-171. (Pubitemid 38208653)
13. Niedobitek, G., D. Päzolt, M. Teichmann, and O. Devergne. 2002. Frequent expression of the Epstein-Barr virus (EBV)-induced gene, EBI3, an IL-12 p40-related cytokine, in Hodgkin and Reed-Sternberg cells. J. Pathol. 198: 310-316. (Pubitemid 35277381)
14. Larousserie, F., E. Bardel, S. Pflanz, B. Arnulf, C. Lome-Maldonado, O. Hermine, L. Brégaud, M. Perennec, N. Brousse, R. Kastelein, and O. Devergne. 2005. Analysis of interleukin-27 (EBI3/p28) expression in Epstein-Barr virus- and human T-cell leukemia virus type 1-associated lymphomas: heterogeneous expression of EBI3 subunit by tumoral cells. Am. J. Pathol. 166: 1217-1228. (Pubitemid 40524444)
15. Larousserie, F., E. Bardel, A. Coulomb-L'Herminé, D. Canioni, N. Brousse, R. A. Kastelein, and O. Devergne. 2006. Variable expression of Epstein-Barr virus-induced gene 3 during normal B-cell differentiation and among B-cell lymphomas. J. Pathol. 209: 360-368. (Pubitemid 43997745)
16. Larousserie, F., P. Charlot, E. Bardel, J. Froger, R. A. Kastelein, and O. Devergne. 2006. Differential effects of IL-27 on human B cell subsets. J. Immunol. 176: 5890-5897.
17. De Waal Malefyt, R., C. G. Figdor, R. Huijbens, S. Mohan-Peterson, B. Bennett, J. Culpepper, W. Dang, G. Zurawski, and J. E. de Vries. 1993. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes: comparison with IL-4 and IFN-γ or IL-10. J. Immunol. 151: 6370-6381. (Pubitemid 23340383)
18. + regulatory T cells in human thymus. Nature 436: 1181-1185.
19. + regulatory T cells. J. Immunol. 175: 4180-4183.
20. + T reg cells. J. Exp. Med. 203: 1701-1711.
21. Seddiki, N., B. Santner-Nanan, J. Martinson, J. Zaunders, S. Sasson, A. Landay, M. Solomon, W. Selby, S. I. Alexander, R. Nanan, et al. 2006. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J. Exp. Med. 203: 1693-1700. (Pubitemid 44036275)
22. + regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo. Blood 108: 1571-1579.
23. Ziegler, S. F. 2006. FOXP3: of mice and men. Annu. Rev. Immunol. 24: 209-226.
24. - T cells. J. Clin. Invest. 112: 1437-1443.
25. + Tregs. J. Clin. Invest. 115: 3276-3284.
26. Gavin, M. A., T. R. Torgerson, E. Houston, P. deRoos, W. Y. Ho, A. Stray-Pedersen, E. L. Ocheltree, P. D. Greenberg, H. D. Ochs, and A. Y. Rudensky. 2006. Single-cell analysis of normal and FOXP-3 mutant human T cells: FOXP3 expression without regulatory T cell development. Proc. Natl. Acad. Sci. USA 103: 6659-6664.
27. - T cells by T-cell receptor stimulation is transforming growth-factor-β-dependent but does not confer a regulatory phenotype. Blood 110: 2983-2990.
28. Roncarolo, M. G., and S. Gregory. 2008. The validity of Foxp3 to define human and mouse regulatory T cells. Eur. J. Immunol. 38: 925-927.
29. + human thymocytes. J. Exp. Med. 196: 379-387.
30. + regulatory thymocytes. Blood 102: 4107-4114.
31. Gavin, M. A., J. P. Rasmussen, J. D. Fontenot, V. Vasta, V. C. Manganiello, J. A. Beavo, and A. Y. Rudensky. 2007. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 445: 771-775. (Pubitemid 46279714)
32. Williams, L. M., and A. Y. Rudensky. 2007. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat. Immunol. 8: 277-284.